Clinical Trial Update: Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum [Phase 2]

View source ↗

Summary

An open-label, Phase 2 trial evaluating meplazumab in adults with Plasmodium falciparum malaria. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Meplazumab (meplazumab)

Snippet

Sponsor: Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd | Conditions: Malaria | Phase 2 | Status: ACTIVE_NOT_RECRUITING